The Australian market is experiencing a challenging period, with shares poised for a decline amid geopolitical tensions and natural disruptions, such as the impact of Tropical Cyclone Narelle on energy operations. In this environment, identifying high growth tech stocks requires a focus on companies with resilient business models and innovative capabilities that can navigate volatility and capitalize on emerging opportunities.

Top 10 High Growth Tech Companies In Australia

Name Revenue Growth Earnings Growth Growth Rating Cogstate 14.14% 23.32% ★★★★★☆ Kinatico 14.71% 62.85% ★★★★☆☆ Clinuvel Pharmaceuticals 20.31% 27.10% ★★★★★★ Pureprofile 11.50% 36.43% ★★★★☆☆ Elsight 41.22% 42.55% ★★★★★★ FINEOS Corporation Holdings 6.06% 39.76% ★★★★☆☆ Oneview Healthcare 26.22% 70.90% ★★★★★☆ Ai-Media Technologies 10.68% 78.35% ★★★★☆☆ Xero 18.63% 24.07% ★★★★☆☆ Echo IQ 120.36% 109.36% ★★★★★★

Click here to see the full list of 25 stocks from our ASX High Growth Tech and AI Stocks screener.

We're going to check out a few of the best picks from our screener tool.

Cogstate

Simply Wall St Growth Rating: ★★★★★☆

Overview: Cogstate Limited is a neuroscience solutions company that focuses on developing, validating, and commercializing digital brain health assessments globally, with a market cap of A$382.67 million.

Operations: Cogstate generates revenue primarily from its Clinical Trials segment, which accounts for $53.59 million, while its Healthcare segment contributes $2.48 million.

Cogstate, a player in the healthcare tech sector, recently showcased robust growth metrics and forward-looking guidance that underscores its upward trajectory. In its latest earnings call for H1 2026, the company reported a notable increase in revenue to $26.92 million from $23.94 million year-over-year and an uplift in net income to $4.53 million from $3.9 million, reflecting a strong execution against its operational goals. Furthermore, Cogstate’s management has set an optimistic tone for the second half of 2026 with expected revenue growth of 24%, buoyed by a record contracted revenue position of $21.7 million—an indicator of sustained demand and strategic sales initiatives. This performance is complemented by Cogstate's commitment to innovation as evidenced by its R&D investments which are pivotal in maintaining competitive advantage within the high-stakes AI-driven healthcare solutions space. The company's recent presentations at industry summits further align with this strategy, potentially catalyzing future growth avenues amidst dynamic market conditions.

Click to explore a detailed breakdown of our findings in Cogstate's health report. Explore historical data to track Cogstate's performance over time in our Past section.

Story Continues

ASX:CGS Revenue and Expenses Breakdown as at Mar 2026

Data#3

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Data#3 Limited is an Australian company that offers information technology solutions and services, with a market capitalization of A$1.04 billion.

Operations: The company generates revenue primarily through three segments: Services (A$262.23 million), Software Solutions (A$70.74 million), and Infrastructure Solutions (A$551.44 million).

Amid a dynamic tech landscape, Data#3 Limited (DTL) stands out with its impressive revenue surge of 32.7% annually, significantly outpacing the Australian market's growth rate of 5.9%. This robust expansion is mirrored in its earnings, which have climbed by 10.8% over the past year and are projected to grow at an annual rate of 8.4%. While this growth is slightly below the broader market expectation of 11.9%, DTL's strategic focus on high-margin segments has resulted in a remarkable forecasted Return on Equity (RoE) of 59% in three years' time. The company’s commitment to innovation and customer-centric solutions was evident at JuiceIT 2026 Perth, showcasing its potential to sustain momentum amidst evolving industry demands.

Take a closer look at Data#3's potential here in our health report. Evaluate Data#3's historical performance by accessing our past performance report.ASX:DTL Revenue and Expenses Breakdown as at Mar 2026

Nuix

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Nuix Limited offers investigative analytics and intelligence software solutions across various regions including the Asia Pacific, the Americas, Europe, the Middle East, and Africa with a market capitalization of A$413.43 million.

Operations: The company generates revenue primarily from its Software & Programming segment, amounting to A$237.49 million. The business focuses on providing specialized software solutions for investigative analytics and intelligence across multiple regions.

In the swiftly evolving tech sector, Nuix has demonstrated notable resilience and strategic acumen, particularly with its recent financial turnaround. After a challenging period, the company reported a significant recovery with half-year sales rising to AUD 121.18 million from AUD 105.19 million in the previous year and swinging from a net loss of AUD 10.4 million to a net profit of AUD 11.08 million. This rebound is underscored by an impressive earnings growth forecast of 29.9% annually, outpacing the broader Australian market's expectation of 11.9%. Additionally, Nuix's focus on expanding its board's expertise through high-caliber appointments like Rachel Barger and Ted Pretty reflects a strategic push to enhance governance and market penetration, especially in critical regions like the U.S., which could further solidify its position in global markets.

Click here to discover the nuances of Nuix with our detailed analytical health report. Learn about Nuix's historical performance.ASX:NXL Revenue and Expenses Breakdown as at Mar 2026

Make It Happen

Click through to start exploring the rest of the 22 ASX High Growth Tech and AI Stocks now. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Seeking Other Investments?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ASX:CGS ASX:DTL and ASX:NXL.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments